Featured Soft Gel Technologies, Inc.® and OptiPure® VendorWorks Presentations at SupplySide East Will Focus on Ubiquinol and Banaba Leaf Extract and Its Role in Blood Glucose Regulation

LOS ANGELES, CA, April 26, 2007—Soft Gel Technologies, Inc.® (SGTI) and OptiPure® will host Andrew Myers, N.D. as a speaker at the SupplySide East trade show in Secaucus, New Jersey, on Tuesday, May 1st at 10:00 a.m. in seminar room E and at 4:00 p.m. in seminar room AB of the Meadowlands Exposition Center. Dr. Myers is a naturopathic physician with nearly 20 years of experience developing new nutritional products. He currently serves as the President and Chief Science Officer of NutraGenetics, and is the author of Simple Health Value. In his first VendorWorks presentation entitled, “Ubiquinol (Kaneka QH™)—The Active Antioxidant,” Dr. Myers will discuss the reduced form of coenzyme Q10 and its benefits. Show attendees are also encouraged to attend the afternoon VendorWorks presentation entitled, “Overcoming Insulin Resistance: Natural Solutions for Blood Glucose Regulation,” where they can learn about the health risks associated with insulin resistance and how natural medicines, including compounds such as corosolic acid from banaba leaf extract, play a role in improving blood glucose metabolism.

Soft Gel Technologies, Inc.® is pleased to offer Kaneka’s QH™ ingredient in a soft gelatin delivery system. This form of CoQ10 has been reduced to an active form and is a highly bioavailable antioxidant. Supplementation with ubiquinol benefits those whose ability to convert this valuable nutrient from its oxidized state (ubiquinone) to its reduced state (ubiquinol)—particularly those who are over 40 years old and individuals whose plasma CoQ10 levels are deficient because of certain chronic diseases.

Insulin resistance causes an elevation in blood glucose levels. Long term elevation of blood sugar creates a high risk for developing full-blown diabetes, along with stroke and heart disease. A standardized banaba leaf extract containing 18% corosolic acid is available exclusively from SGTI and OptiPure® may help maintain healthy blood glucose levels, thereby decreasing the risk of long-term complications associated with insulin resistance.

SGTI President, Ron Udell, commented, “Education is a key component in creating understanding and gaining acceptance for new products. We are pleased to have Dr. Myers speak on behalf of Soft Gel Technologies, Inc.® and OptiPure®.” SGTI and OptiPure will exhibit at booth numbers 1518 &1520 at SupplySide East.

About Soft Gel Technologies, Inc.®
Soft Gel Technologies, Inc.® is a leading contract manufacturer providing specialty soft gelatin encapsulation to the nutrition industry. SGTI’s leading product is a patented, highly bioavailable CoQ10 soft gel marketed as CoQsol®. Other key products include GlucoFit™, a banaba leaf extract for blood glucose management, and Injuv®, a low molecular weight hyaluronic acid for cosmeceutical and joint health applications. Soft Gel Technologies, Inc.® is a privately-held company based in Los Angeles, CA.

About OptiPure®
OptiPure® is a leading distributor of unique branded nutraceutical ingredients in addition to being a leading distributor of Japanese CoQ10. OptiPure® is a privately held company based in Los Angeles, CA.

For more information, visit www.soft-gel.com or www.optipure.com.

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.